Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas

<table>Immunohistochemical staining for CD44v6 protein in ovarian carcinomas, DAB <svg height="11.125" id="M9" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 34.575001 11.125" width="34.575001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M528 54l-36 -38l-198 201l-198 -201l-36 38l197 200l-197 201l36 38l198 -202l198 202l36 -38l-197 -201z" id="xD7"></path></g><g transform="matrix(.017,-0,0,-.017,10.041,10.862)"><path d="M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z" id="x34"></path></g><g transform="matrix(.017,-0,0,-.017,18.2,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,26.36,10.862)"><use xlink:href="#x30"></use></g>
</svg>. (a) Negative control of ovarian carcinoma. (b–f) Membranous staining of tumor cells.</table>

Pathology Research International

fig1

Figure 1

Figure 1: Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas 